INDV
Indivior Pharmaceuticals, Inc.
Stock
$35.71+0.33 (+0.93%)Close Oct 2, 2026
Cash flow statement
| Line | Last 12 months | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Operating cash flow | −$40M | −$27M | $36M | −$300M | −$4.0M | — |
| Capital expenditures | $71M | $66M | $29M | $8.0M | $5.0M | — |
| Free cash flow | −$111M | −$93M | $7.0M | −$308M | −$9.0M | — |
| Stock-based compensation | $32M | $26M | $24M | $21M | $16M | $11M |
| Buybacks | $302M | $11M | $173M | $33M | $90M | $101M |
| Free cash flow margin | −8.3% | −7.5% | 0.6% | −28.2% | −1.0% | — |